Amylin (human); IAPP (human), Islet Amyloid Polypeptide (human)

Amylin (human); IAPP (human), Islet Amyloid Polypeptide (human)

122384-88-7

C₁₆₅H₂₆₁N₅₁O₅₅S₂

dap (human) ; amylin, dap, iapp ; insulinoma ; dap amide, human ; diabetes-associatedpeptide (human) ; human islet amyloid peptide ; iapp (human) ; human iapp ; amylin ; amlintide [usan:inn] ; l-lysyl-l-cysteinyl-l-asparaginyl-l-threonyl-l-alanyl-l-threonyl-l-cysteinyl-l-alanyl-l-threonyl-l-glutaminyl-l-arginyl-l-leucyl-l-alanyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-valyl-l-histidyl-l-seryl-l-seryl-l-asparaginyl-l-asparaginyl-l-phenylalanylglycyl-l-alanyl-l-isoleucyl-l-leucyl-l-seryl-l-seryl-l-threonyl-l-asparaginyl-l-valylglycyl-l-seryl-l-asparaginyl-l-threonyl-l-tyrosinamide, cyclic (2-7)-disulfide ; 7)-disulfide ; dap ; l-tyrosinamide, l-lysyl-l-cysteinyl-l-asparaginyl-l-threonyl-l-alanyl-l-threonyl-l-cysteinyl-l-alanyl-l-threonyl-l-glutaminyl-l-arginyl-l-leucyl-l-alanyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-valyl-l-histidyl-l-seryl-l-seryl-l-asparaginyl-l-asparaginyl-l-phenylalanylglycyl-l-alanyl-l-isoleucyl-l-leucyl-l-seryl-l-seryl-l-threonyl-l-asparaginyl-l-valylglycyl-l-seryl-l-asparaginyl-l-threonyl-, cyclic (2-7)-disulfide ; amlintide ; iapp ; amylin, human ; l-tyrosinamide,l-lysyl-l-cysteinyl-l-asparaginyl-l-threonyl-l-alanyl-l-threonyl-l-cysteinyl-l-alanyl-l-threonyl-l-glutaminyl-l-arginyl-l-leucyl-l-alanyl-l-asparaginyl-l-phenylalanyl-l-leucyl-l-valyl-l-histidyl-l-seryl-l-seryl-l-asparaginyl-l-asparaginyl-l-phenylalanylglycyl-l-alanyl-l-isoleucyl-l-leucyl-l-seryl-l-seryl-l-threonyl-l-asparaginyl-l-valylglycyl-l-seryl-l-asparaginyl-l-threonyl-,cyclic (2® ; 1,2-dithia-5,8,11,14,17-pentaazacycloeicosane,cyclic peptide deriv ; diabetes-associated peptide amide human ; ac 001 ; amylin, human, amide ; human amylin ; amylin (human)